Purification of the Human Interferon-γ Receptor by Ligand Affinity

  • Daniela Novick
  • Dina G. Fischer
  • Menachem Rubinstein
Part of the Receptor Purification book series (RP, volume 1)


Interferon-γ(IFN-γ) is a product of activated T lymphocytes (Kasahara et al., 1983) and low density lymphocytes (Fischer and Rubinstein, 1983). In addition to its antiviral and growth inhibitory activities, IFN-γis one of the major immunoregulatory lymphokines. Its immunoregulatory functions include macrophage activation, growth, differentiation, and maturation of various immunocytes and induction of class I and II MHC gene products both in macrophages and in cells of nonhematopoietic origin (for a review see Trinchieri and Perrusia, 1985). A survey of its various activities reveals that IFN-γelicits 50% of its maximal effect at concentrations of 0.5-1 pM. Indeed, the level of IFN-γ in blood or in other tissue fluids rarely exceeds the lower limit of detection, which is about 10 antiviral U/mL (10 pM). Therefore, a highly sensitive and selective system must be present in the cells in order to trace IFN-γ and respond to it. Such a system is the cell surface receptor. In this respect, IFN-γ is similar to other polypeptide hormones, lymphokines, and other cytokines, all acting through specific cell-membrane receptors. This array of polypeptides and their receptors serve as an efficient chemical signaling network that is essential for the existence of multicellular organisms.


HeLa Cell Ascitic Fluid Cold Phosphate Buffer Saline Immunoaffinity Chromatography Nitrocellulose Sheet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aguet, M. and Merlin, G. (1987), J. Interferon Res. 7, 683 (Abstract).CrossRefGoogle Scholar
  2. Aguet, M. and Merlin, G. (1987), J. Exp. Med. 165, 988–999.PubMedCrossRefGoogle Scholar
  3. Bolton, A. E. and Hunter, M. W. (1973), Biochem. J. 133, 529–539.PubMedGoogle Scholar
  4. Calderon, J., Sheehan, K. C. F., Chance, C., Thomas, M. L., and Schreiber, R. D. (1988), Proc. Natl. Acad. Sci. USA 85, 4837–4841.PubMedCrossRefGoogle Scholar
  5. Eshhar, Z., Ofarim, M., and Waks, T. (1980), J. Immunol. 124, 775–780.PubMedGoogle Scholar
  6. Finbloom, D. S., Hoover, D. L., and Wahl, L. M. (1985), J. Immunol. 135, 300–305.PubMedGoogle Scholar
  7. Fischer, D. G. and Rubinstein, M. (1983), Cellular Immunol. 81, 426–434.CrossRefGoogle Scholar
  8. Fischer, D. G., Novick, D., Orchansky, P., and Rubinstein, M. (1988), J. Biol. Chem. 263, 2632–2637.PubMedGoogle Scholar
  9. Hock, R. A. and Hollenberg, M. D. (1980), J. Biol. Chem. 255,10731–10736.PubMedGoogle Scholar
  10. Hunter, M. W. (1978) in The Handbook of Experimental Immunology. (Weir, D. M., ed.), Blackwell Press, Oxford, Chapter 14, p. 141.Google Scholar
  11. Kasahara, T., Hooks, J. J., Dougherty, S. F., and Oppenheim, J. J. (1983), J. Immunol. 130 1784–1789.PubMedGoogle Scholar
  12. Laemmli, U. K. (1970), Nature 227,680–685.PubMedCrossRefGoogle Scholar
  13. Leonard, W. J., Depper, J. M., Crabtree, G. R., Rudikoff, S., Pumphery, J., Robb, R. J., Kronke, M., Svetlik, P. B., Peffer, N. J., Waldman, T. A., and Greene, W. C. (1984), Nature 311 626–635.PubMedCrossRefGoogle Scholar
  14. Littlefield, T. W. (1964), Science 145 709.PubMedCrossRefGoogle Scholar
  15. Mory, Y., Ben-Barak, J., Segev, D., Cohen, B., Novick, D., Fischer, D. G., Rubinstein, M., Kargman, S., Zilberstein, A., Vigneron, M., and Revel, M. (1986), DNA 5,181–193.PubMedCrossRefGoogle Scholar
  16. Munson, P. J. and Rodbard, D. (1980), Anal. Biochem. 107, 220–239.PubMedCrossRefGoogle Scholar
  17. Novick, D., Eshhar, Z., and Rubinstein, M. (1982), J. Immunol. 129, 2244–2247.PubMedGoogle Scholar
  18. Novick, D., Eshhar, Z., Gigi, O., Fischer, D. G., Friedlander, J., and Rubinstein, M. (1983), EMBO J. 2,1527–1530.PubMedGoogle Scholar
  19. Novick, D., Orchansky, P., Revel, M., and Rubinstein, M. (1987), J. Biol. Chem. 262, 8483–8487.PubMedGoogle Scholar
  20. Novick, D., Fischer, D. G., Reiter, Z., Eshhar, Z., and Rubinstein, M. (1989), J. Interferon Res. 9 315–328.PubMedCrossRefGoogle Scholar
  21. Oakley, B. R., Kirsh, D. R., and Morris, N. R. (1980), Anal. Biochem. 105 361–363.PubMedCrossRefGoogle Scholar
  22. Orchansky, P., Rubinstein, M., and Fischer, D. G. (1986), J. Immunol. 136,169–173.PubMedGoogle Scholar
  23. Rubinstein, S., Familletti, P. C., and Pestka, S. (1981), J. Virl. 37, 755–758.Google Scholar
  24. Rubinstein, M., Fischer, D. G., and Orchansky, P. (1986) in Interferons as Cell Growth Inhibitors and Antitumor Factors (R. M. Friedman, T. Merigan, and T. Sreevalsan, eds.), Alan R. Liss Inc., New York, pp. 269–278.Google Scholar
  25. Sarkar, F. H. and Gutpa, S. L. (1984), Proc. Natl. Acad. Sci. USA 81,5160–5164.PubMedCrossRefGoogle Scholar
  26. Stein, S. and Moschera, J. (1981), Methods Enzymol. 79, 7–16.PubMedCrossRefGoogle Scholar
  27. Trinchieri, G. and Perussia, B. (1985), Immunol. Today 6131–136.CrossRefGoogle Scholar
  28. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, W., Lee, J., Yarden, Y., Liberman, T. A., Schlessinger, J., Downward, J., Mayes, E. L. V., Whittle, N., Waterfield, M. D., and Seeburg, P. H. (1984), Nature 309,418–425.PubMedCrossRefGoogle Scholar
  29. Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., Tsubokawa, M., Mason, A., Seeburg, P. H., Grunfeld, C., Rosen, O. M., and Ramachandran, A. (1985), Nature 313 756–761.PubMedCrossRefGoogle Scholar
  30. Wilchek, M. and Miron, T. (1974), Methods Enzymol. 34,72–76.PubMedCrossRefGoogle Scholar
  31. Zola, H. and Brooks, D. (1986) in Monoclonal Hybridoma Antibodies: Techniques and Applications (J. G. R. Hurrel, ed.), CRC Press, Inc., Boca Raton, Florida, pp. 34, 35.Google Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Daniela Novick
  • Dina G. Fischer
  • Menachem Rubinstein

There are no affiliations available

Personalised recommendations